1 / 50

Good Samaritan Hospital Hypothermia Therapy : A New Frontier in Reducing Morbidity and Mortality in the Post-Cardiac Arr

Good Samaritan Hospital Hypothermia Therapy : A New Frontier in Reducing Morbidity and Mortality in the Post-Cardiac Arrest Patient Missi Chittum RN, BSN Vickie Wolnitzek RN, BSN. Sudden cardiac arrest (SCA) is a leading cause of death in the US

sol
Télécharger la présentation

Good Samaritan Hospital Hypothermia Therapy : A New Frontier in Reducing Morbidity and Mortality in the Post-Cardiac Arr

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Good Samaritan Hospital Hypothermia Therapy : A New Frontier in Reducing Morbidity and Mortality in the Post-Cardiac Arrest Patient Missi Chittum RN, BSN Vickie Wolnitzek RN, BSN

  2. Sudden cardiac arrest (SCA) is a leading cause of death in the US • Approximately 295,000 US out-of-hospital arrest per year • Less than 10% of people who present to the hospital survive to discharge • Up to 65% initially comatose survivors suffer debilitating neurological outcomes • Roger VL,Go AS, Lloyd-James DM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association Statistics . CIRCULATION. 2011:123(4)c18-c209. Scope of the Problem:

  3. What is Mild Therapeutic Hypothermia? • Clinically induced hypothermia 32-34 degrees for 12-24 hours within 4 to 8 hours of spontaneous circulation (ROSC) • Evidence based care • Brain-protective treatment to prevent/reduce reperfusion injury following cardiac arrest and return of circulation • Improves chance for good neurological outcome AHA Guidelines for Cardiopulmonary Resuscitation and Emergency CV Care. Part 9. CIRCULATION 2010

  4. 1950s: First described but with no formal testing • 1960s: Temperature targets were 28-32°C and research •                     findings were not favorable • 1980s: Revival of interest using dogs after cardiac arrest •   with temperature targets of 32-34°C had positive •   outcomes • 1990s: Therapeutic hypothermia was revisited: • Can we safely cool patients? • What is the best cooling method? • 2000s: Using evidence based practice from prior •                     research trials History of Therapeutic Hypothermia

  5. Evidence Based Research: 1. Dr. Bernard’ s study- one of the first 2. Mauro Oddo study –appropriate temperature range 3. HACA- a larger group of people with positive     outcomes 4. Sebastian Wolfrum- showed it was possible to Hypothermia Therapy along side PCI despite the higher risk of bleeding with anticoagulants

  6. European study • Decrease in mortality and •       improved neurological outcomes • 77 patients •         - 43 hypothermia •         - 34 normothermia • Results •          -49% of hypothermic patients had good outcomes • compared to 26% normothermic patients • Bernard SA, et al. “Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.” NEJM 2002; 346 (8): 546-556. Dr. Bernard’s Study

  7. Researcher Mauro Oddo • Implementation Study • 109 comatose out of hospital arrests • Retrospective • Determined feasibility of Therapeutic Hypothermia (TH) to 33 degrees C in clinical practice • VF as initial rhythm • Good outcomes: TH 56% , standard care 26% • TH safely applied to patients with initial rhythm of PEA and asystole. Outcomes were poor, though the subset was small • Oddo M. et al. from evidence to clinical practice : Effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest. Critical Care Medicine 2006: 34 (7): 1865-1873 Mauro Oddo:

  8. HACA Study (Hypothermia After Cardiac Arrest) • Multi-center trial • 275 patients • - 137 Hypothermia • - 138 Normothermia • Results • - 55% Hypothermia group favorable outcome • - 39% Normothermia group favorable outcome • The Hypothermia After Cardiac Arrest Study Group. “Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.” NEJM 2002 ; 346 (8): 549-556.

  9. Objective: Is it feasible, safe, and beneficial to combine hypothermia therapy with percutaneous intervention(PCI)? • Patients: 33 cardiac arrest w/ v-fib, ROSC, unconscious , and with acute ST elevation MI (STEMI) • Results: • Did not result in longer door-to-balloon times • Target temp was reached w/i 4 hours • No increase in bleeding complications & infections • Trend toward lower mortality (25% vs 35%) • Improved neurologic outcome Wolfrum German Study

  10. AHA 2010 Post Arrest Guidelines • Post VF arrest patients who are unresponsive with a ROSC after 0ut-of-hospital cardiac arrest should be cooled to: • 32 ° C to 34 °C • Duration of 12-24 hours • Therapeutic Hypothermia (TH) may also be considered for • comatose adult patients with ROSC after initial rhythm is PEA or asystole • Therapeutic Hypothermia can be considered for in-hospital • arrests • 4. Transport patients to appropriate hospitals that can manage • and implement post cardiac arrest care to include TH • AHA Guidelines for Cardiopulmonary Resuscitation and Emergency CV Care. Part 9. CIRCULATION 2010

  11. Pathophysiology… • Cardiac arrest = No blood flow to the brain • Depletes brain O2 stores within 20 seconds • Results in irreversible brain damage if circulation is not restored. • Research has proven that it is not the lack of oxygen during the arrest that causes brain death, yet it is the release of oxygen free radicals into the brain that causes post cardiac arrest brain injury when circulation is restored

  12. More Pathophysiology…

  13. Benefits of Therapeutic Induced Hypothermia • Cerebral metabolism will decrease by 5%-7%for every 1° C reduction in core body temperature (Oku et al.,1993) • Reduces intercellular acidosis • Decreases the inflammatory response and cytokines release • Protects the blood brain lipomembranes

  14. Complications of Therapeutic Hypothermia • Depressed myocardial function • Dysrhythmias • Coagulopathy • Immunosupression • Fluid and electrolyte imbalances • Slow drug metabolism

  15. Initial temperature > 30 degrees C • No command following • NO level of brain death precludes cooling Inclusion Criteria Post cardiac arrest (VF/pulseless VT) Witnessed arrest Time of collapse to ROSC <30 minutes Initiation of therapy within 6 hours of arrest time

  16. MAP < 60 mmHg for > 30 mins and requiring > 1 pressor • Uncontrolled cardiac arrhythmias • History of Cryoglobulinemia • Pregnacy Exclusion Criteria DNR, terminal illness, poor baseline function Hemorrhagic CVA, status epilepticus Active severe bleeding Trauma until ruled out

  17. The most important exclusion to remember is… Don’t chill the awake and talking patient! Please don’t freeze me!!!

  18. Key Clinical Priorities: Pre-Induction Phase (Time Sensitive) • Confirm witnessed v-fib arrest • EMS-consider transporting patient to hospital with hypothermia therapy • Determine ROSC time • Patient not responsive and following commands • Initiate cooling- mechanism dependent on where patient is • EKG – AMI requiring PCI • Record Glasgow Coma score

  19. Key Clinical Priorities:Induction Phase Head CT Record an initial temperature- rectal the best Central line placement Continue cooling method Baseline labs Initiate sedation/paralytic meds Shivering Transfer to appropriate critical care unit

  20. Key Clinical Priorities:Maintenance Phase Focus on cardiac & cerebral resuscitation Nursing care 1:1 Maintain existing cooling methods Use hospital approved cooling method and temperature monitoring device Monitor patient for side effects and complications

  21. Importance of Rewarming Phase… Rewarming should occur at 0.3 to 0.5 °Celsius per hour Avoid complications of rapid rewarming, i.e. dangerous electrolyte shifts and rebound hyperthermia Monitor lab values: K+ will increase & glucose decrease Discontinue sedation and paralytics once goal temp is achieved

  22. Physiologic Effects of Hypothermia Therapy by Body Systems

  23. Cardiovascular Ventricular arrhythmias- atrial and ventricular fibrillation Myocardial depression, bradycardia, AV block Increased SVR, decreased CO, decreased contractility

  24. Respiratory Decreased RR Hypoventilation Suppression of cough and mucociliary reflexes from hypothermia therapy may lead to hypoxemia, atelectasis, and pneumonia Shift in oxyhemoglobin dissociation curve to the left (less oxygen is released from oxyhemoglobin to the soft tissues)

  25. Metabolic Hypothermia will cause glucose levels to elevate When shivering is allowed, there is an increase in glucose utilization and levels then can remain NORMAL Yet shivering increases the metabolic rate, CO2 production and O2 consumption and myocardial work Slowed drug metabolism

  26. Gastrointestinal Decreased motility, liver function, Ileus Stress Ulceration

  27. Renal ↑ urine output ↑ loss of electrolytes ↓ creatinine clearance Tubular dysfunction

  28. Electrolyte Shifts Find graph/picture

  29. Hematologic Increased blood viscosity (hemoconcentration) Platelet dysfunction

  30. Initiate quickly as possible w/ goal to reach temperature 6 hours after ROSC • Goal: 33°C / 91.4°F • Period of 24 hours once goal temp is achieved Cooling methods…

  31. Cooling Methods Surface cooling with ice packs Surface cooling with cooling blanket Cool room Fan Moist towels and exposed skin Use your hospital approved cooling device

  32. Other Methods of Cooling: Internal cooling with infusion of cool IV fluids Internal cooling with gastric lavage of iced saline

  33. Cooling Blankets:

  34. Cooling Blanket Thermo regulates to preset patient goal temperature 33° C with the use of a rectal or esophageal probe

  35. Cooling Method: Endovascular Device

  36. Core Cooling Methods

  37. Pharmacological Agents for Prevention of Shivering

  38. Nursing Care

  39. Interdisciplinary Collaboration • Champions • Pre-hospital care • ER • Cath Lab • Intensivists • Cardiologists • Pharmacy • Critical Care Units • Family

  40. Lessons Learned

  41. Starting a Program Usman Omar.8 Key Principes for Success. Muslim Strategic Initiative 2011

  42. Successes

  43. What Does The Future Hold? • Research using the new sophisticated internal and external cooling devices • Increased research to determine the optimal time to target temperature and the rates of cooling and rewarming • Future advances will require earlier initiation of therapy either prior to cardiac arrest or during CPR • Hydrogen sulfide to induce a hibernation-like state in animals seems to hold promise

  44. Studies have shown that only 6 patients need to receive therapeutic hypothermia for 1 life to be saved. • The ONLY supportive therapy for favorable neurological outcomes after an arrest • The faster hypothermia therapy is induced, the better the outcomes • Cool them down instead of warm them up Concluding Thoughts…

  45. Hypothermia Therapy: COOL MEDICINE… Are you doing it?

  46. References Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Eng J Med 2002; 346(8):557-563. Nair SU, Lundbye JB. The use of hypothermia therapy in cardiac arrest survivors. Therapeutic Hypothermia and Temperature Management 2011; 1(1):9-21. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Eng J Med, Feb 21 2002. 346(8): p. 549-56. Peberdy MA, Callaway CS, Neumar RW, et al. Part 9:post-cardiac arrest care: 2010 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010; 122(18 supp 3):S768-S786. Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med. 2009; 37(supp 7):S186-S202. Harden J. Take a cool look at therapeutic hypothermia. Nursing 2011. 2011;41(9):p 46-51. Oddo M, Schaller MD, Feihl F, Ribordy V, Liaudet L. From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest. Crit Care Med. 2006 Jul; 34(7):1865-73. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association Statistics. Circulation. 2011; 123(4):c18-c209. Bahrt G. Cooler heart, better odds: Induced hypothermia. Nursing Management. 2009 Jul; 40(7):22-29. Oku K, Sterz F, Safar P, Johnson D, Obrist W, Leonov Y, Kuboyama K, Tisherman SA, Stezoski SW. Mild hypothermia after cardiac arrest in dogs does not affect postarrest multifocal cerebral hypoperfusion. Stroke 1993:24:1590-1597 Hypothermia cooling techniques. Resuscitation Central. Online 12 November 2011. Wolfrum S. Pieerau C, Radke PW, Schnkert H, Kurowski V. Mild therapeutic hypothermia in patients after out of hospital cardiac arrest due to accute ST elevation myocardial infarction undergoing immediate percutaneous coronary intervention Crit Care Med 2008 Jun;36(6):1780-6

More Related